PlainRecalls
FDA Drug Moderate Class II Terminated

Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.

Reported: April 1, 2020 Initiated: March 6, 2020 #D-1059-2020

Product Description

Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.

Reason for Recall

CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.

Details

Recalling Firm
Nostrum Laboratories Inc
Units Affected
4722 bottles
Distribution
TN, MO
Location
Kansas City, MO

Frequently Asked Questions

What product was recalled?
Theophylline (Anhydrous) Extended-Release Tablets, 400 mg, 100-count bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120, NDC 29033-001-01.. Recalled by Nostrum Laboratories Inc. Units affected: 4722 bottles.
Why was this product recalled?
CGMP Deviations: poor manufacturing practices resulted in Labeling: Incorrect or Missing Lot and/or Exp Date, product incorrectly labeled with incorrect lot and expiration date.
Which agency issued this recall?
This recall was issued by the FDA Drug on April 1, 2020. Severity: Moderate. Recall number: D-1059-2020.